Diagnos Laboratorium Utama Tbk. vs Indosat Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Indosat Tbk. trades at Rp1,885 (market cap 61.12T, 16.17M 24h volume). The key difference: Indosat Tbk. is far larger — about 198.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Indosat Tbk. is more actively traded (16.17M versus 129.6K). Which is the better fit depends on your goals.
| DGNS | ISAT | |
|---|---|---|
Market Cap | 308B | 61.12T |
Volume | 129.6K | 16.17M |
Lot | 1.3K | 161.66K |
Turnover | 28.71M | 30.64B |
Average Price | 221.54 | 1,895.38 |
Value | 28.71M | 30.64B |
Indicative Equilibrium Price | 230 | 1,885 |
Indicative Equilibrium Volume | 110 | 18.21K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Read more on ISAT →